Skip to main content
Terug
OSCR logo

Oscar Health, Inc.

Datakwaliteit: 100%
OSCR
NYSE Healthcare Medical - Healthcare Plans
€ 12,03
▼ € 0,18 (-1,47%)
Marktkapitalisatie: 3,12B
Dagbereik
€ 11,96 € 12,46
52-Weeksbereik
€ 11,20 € 23,80
Volume
4.861.418
50D / 200D Gem.
€ 14,26 / € 16,25
Vorige Slotkoers
€ 12,21

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (627 peers)

Metriek Aandeel Sector Mediaan
P/E -7,0 0,3
P/B 3,2 2,9
ROE % -44,5 3,7
Net Margin % -3,8 3,8
Rev Growth 5Y % 57,1 10,0
D/E 0,4 0,2

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2028 € 1,88
€ 1,22 – € 2,31
 22 B 3
FY2027 € 1,11
-€ 0,11 – € 1,86
 20 B 6
FY2026 € 0,38
-€ 1,19 – € 1,40
 19 B 5

Belangrijkste Punten

Revenue grew 57,10% annually over 5 years — strong growth
Earnings declined -1842,49% over the past year
Debt/Equity of 0,44 — conservative balance sheet
Generating 1,06B in free cash flow
PEG of 0,01 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 29,60%

Groei

Revenue Growth (5Y)
57,10%
Revenue (1Y)27,50%
Earnings (1Y)-1842,49%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-44,51%
ROIC-21,12%
Net Margin-3,79%
Op. Margin-3,39%

Veiligheid

Debt / Equity
0,44
Current Ratio0,95
Interest Coverage-22,52

Waardering

P/E Ratio
-7,04
P/B Ratio3,19
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 27,50% Revenue Growth (3Y) 41,27%
Earnings Growth (1Y) -1842,49% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 57,10% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 11,70B Net Income (TTM) -443,15M
ROE -44,51% ROA -7,01%
Gross Margin 14,38% Operating Margin -3,39%
Net Margin -3,79% Free Cash Flow (TTM) 1,06B
ROIC -21,12% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,44 Current Ratio 0,95
Interest Coverage -22,52 Dividend Yield 0,00%
Valuation
P/E Ratio -7,04 P/B Ratio 3,19
P/S Ratio 0,27 PEG Ratio 0,01
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 3,12B Enterprise Value 775,00M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 11,70B 9,18B 5,86B 4,13B 1,92B
Net Income -443,15M 25,43M -270,73M -606,28M -572,61M
EPS (Diluted) -1,69 0,10 -1,22 -2,85 -3,19
Gross Profit 1,68B 1,84B 1,22B 4,13B 1,92B
Operating Income -396,36M 57,27M -235,62M -610,08M -570,58M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6,33B 4,84B 3,60B 4,53B 3,32B
Total Liabilities 5,34B 3,82B 2,80B 3,63B 1,93B
Shareholders' Equity 977,65M 1,01B 803,97M 890,38M 1,39B
Total Debt 430,10M 299,56M 298,78M 298,00M 0,0
Cash & Equivalents 2,77B 1,53B 1,87B 1,56B 1,10B
Current Assets 4,61B 2,85B 2,07B 4,12B 2,77B
Current Liabilities 4,86B 3,17B -175,28M 3,26B 1,62B

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#106 of 618
66
Custom Full Throttle
#104 of 146
33

Recente Activiteit

Ingestapt Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt Full Throttle
Mar 24, 2026